Rare Nutrient Model
A Regulatory Architecture Framework for Structured Longevity
MitoQure Initiative
Shigeki Takemoto, MD, PhD
1. Executive Summary
The Problem of Reactive Medicine
The Emergence of Regulatory Architecture
Definition of Rare Nutrients
Strategic Implications
2. Why a New Biological Framework is Needed
2.1 The Limits of Additive Healthcare
2.2 Aging as Regulatory Lock-In
2.3 From Damage Accumulation to State Persistence
3. Evolutionary Mismatch and Regulatory Depletion
3.1 Human Evolutionary Bioenergetics
3.2 Modern Environmental Distortion
3.3 Control Node Fatigue
4. Biological Control Architecture
4.1 Mitochondrial Centrality
4.2 NAD⁺-Dependent Signaling
4.3 Redox Oscillation
4.4 Heme-Linked Metabolic Flux
4.5 Epigenetic Plasticity
5. Defining Rare Nutrients
5.1 Operational Criteria
5.2 Regulatory Modulators vs Substrate Supplementation
5.3 Nonlinear and Context-Dependent Modulation
6. Prototype Framework: The Three Arrows of Anti-Aging®
6.1 Conceptual Integration
6.2 NMN
6.3 5-ALA
6.4 Molecular Hydrogen
6.5 System-Level Synergy
7. Distinction from Conventional Supplement Models
Additive vs Regulatory
Linear vs Adaptive
Symptom vs Control Node
8. Clinical and Ethical Positioning
8.1 Non-Therapeutic Framework
8.2 Integration with Institutional Medicine
8.3 Risk Transparency
9. Strategic Implications
9.1 Digital Health Integration
9.2 Corporate Longevity Programs
9.3 Demographic Adaptation Strategy
9.4 Climate-Stress Resilience Context
10. Research Agenda
Biomarker Mapping
Mitochondrial Phenotyping
Plasticity Metrics
Longitudinal Validation
11. Conclusion
Regulatory Stability as the Foundation of Structured Longevity
Appendix
A. Scientific References
B. Conceptual Diagrams
C. Terminology Definitions
D. Disclosure Statement